Agilon Health Inc. (NYSE: AGL) reported Q4 EPS of ($0.14), $0.04 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $690 million versus the consensus estimate of $664.35 million.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.